but effective with other symptoms such as impulsivity . . .
by Kristina Fiore, Associate Editor, MedPage Today, 06/24/2016
Although they did have improvements in measures of impulsivity and inattention, Parkinson’s patients with mild cognitive impairment (MCI) did not display improved cognition when treated with atomoxetine, a drug commonly used to treat attention deficit-hyperactivity disorder.
If you want to receive an email notification every time a new article on these topics is posted, Subscribe to our article postings!